Current Study: A6B

Purpose:
• To determine how the investigational drug is absorbed, broken down, and removed from the body in individuals with kidney impairment when compared to individuals with a normal level of kidney function.
• Information regarding safety and side effects that may occur will also be collected.
• This study is for research purposes only and is not intended to treat your kidney disease.

Method of Administration: Single oral dose of study drug

Investigator: Thomas Marbury, MD

To qualify:

• 18 to 80 years old
• Must have kidney impairment or disease
• May be seeing a nephrologist, have reduced kidney function, or low creatinine clearance and taking medicine such as:

• Procrit®, Epogen®, or Aranesp® for low blood count
or
• PhosLo for high blood phosphorus

Length/Duration:
• 1 eligibility screening visit
• 8 days and 7 nights in our research facility

Location: 5055 South Orange Avenue, Orlando, FL 32809

Qualified participants will receive study medication, study related physical exams and laboratory tests

Compensation Qualified participants will be compensated up to $3,525 for time and travel

Whom to Contact Recruitment Department: 407-240-7876